You will lead how our earliest oncology assets progress from Phase 2 decisions through registration and launch, shaping evidence, access and diagnostic strategies that reflect local standards of care and payer expectations
Job Summary
You will lead how our earliest oncology assets progress from Phase 2 decisions through registration and launch, shaping evidence, access and diagnostic strategies that reflect local standards of care and payer expectations.
Own Oncology-specific iLVA policy, criteria, and templates; define explicit no-go thresholds and fast-track pathways to enable timely, data-driven decisions.
Here your decisions directly shape how cutting-edge oncology medicines reach patients sooner, with real ownership to adapt for local standards of care and payer needs.
Matching Summary
You will lead how our earliest oncology assets progress from Phase 2 decisions through registration and launch, shaping evidence, access and diagnostic strategies that reflect local standards of care and payer expectations.
Skills & Requirements
Must-have
Oncology asset strategy
Phase 2 through registration and launch
International market archetypes
Evidence generation for payers
Companion diagnostics strategy
Cross-functional leadership
Nice-to-have
Entrepreneurial thinking
Adapt for local standards
Leveraging big data
Learning from colleagues
Key Requirements
Advanced scientific qualification (MD, PhD, or PharmD)